Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
861 to 880 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01AI144365 | Cellular and humoral immunity in Lyme arthritis | 1 | 2023 |
| R01AI145862 | Decidual NK response to infection | 1 | 2023 |
| R01AI145997 | Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection | 1 | 2023 |
| R01AI148080 | Targeting natural killer cells to enhance HIV vaccine responses | 1 | 2023 |
| R01AI150241 | Bidirectional metabolic signaling in follicular helper T cell differentiation | 1 | 2023 |
| R01AI150514 | Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance | 1 | 2023 |
| R01AI153098 | Triggering germline-encoded broadly neutralizing antibody responses against influenza virus | 1 | 2023 |
| R01AI158013 | Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic | 1 | 2023 |
| R01AR063611 | Genetic and Genomic Dissection of Psoriatic Arthritis | 1 | 2023 |
| R01AR073196 | Kallikrein-PAR interactions in skin inflammation | 1 | 2023 |
| R01AR073228 | Transcription Factor Genetics in Lupus | 1 | 2023 |
| R01AR073252 | IL-26 in host defense against infection by intracellular bacteria in skin | 1 | 2023 |
| R01AR075906 | T resident memory cells in arthritis | 1 | 2023 |
| R01AR075959 | Harnessing Human Dendritic Cell Subsets in Skin for the Design of Novel Immunotherapies | 1 | 2023 |
| R01CA203737 | Targeting HER2-low breast cancer with 17p loss | 1 | 2023 |
| R01CA211695 | Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment | 1 | 2023 |
| R01CA214494 | Molecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer | 1 | 2023 |
| R01CA226879 | Functional Activation of Low Affinity TILs | 1 | 2023 |
| R01CA228135 | Mechanisms of enhancer regulation in leukemia | 1 | 2023 |
| R01CA232256 | An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=44